1.528
8.15%
+0.118
전일 마감가:
$1.41
열려 있는:
$1.6
하루 거래량:
161.03K
시가총액:
$86.87M
수익:
-
순이익/손실:
$-112.38M
주가수익비율:
-0.7454
EPS:
-2.05
순현금흐름:
$-83.38M
1주 성능:
+18.21%
1개월 성능:
+6.64%
6개월 성능:
+120.68%
1년 성능:
+48.05%
Passage Bio Inc Stock (PASG) Company Profile
명칭
Passage Bio Inc
전화
267 866 0311
주소
One Commerce Square, 39th Floor 2005 Market Street, Philadelphia, PA
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-03-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2022-01-19 | 다운그레이드 | Goldman | Buy → Neutral |
2021-07-01 | 개시 | Raymond James | Outperform |
2021-06-15 | 개시 | BTIG Research | Buy |
2021-03-04 | 업그레이드 | Goldman | Neutral → Buy |
2021-02-04 | 개시 | Guggenheim | Buy |
2021-01-25 | 개시 | Wedbush | Outperform |
2021-01-04 | 업그레이드 | JP Morgan | Neutral → Overweight |
2020-12-11 | 개시 | Citigroup | Neutral |
2020-08-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2020-06-25 | 다운그레이드 | Goldman | Buy → Neutral |
2020-03-25 | 개시 | Chardan Capital Markets | Buy |
2020-03-24 | 개시 | Cowen | Outperform |
2020-03-24 | 개시 | Goldman | Buy |
2020-03-24 | 개시 | JP Morgan | Overweight |
모두보기
Passage Bio Inc 주식(PASG)의 최신 뉴스
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
GlobeNewswire Inc.
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
GlobeNewswire Inc.
Passage Bio to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
GlobeNewswire Inc.
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
Benzinga
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
GlobeNewswire Inc.
Passage Bio Inc (PASG) 재무 분석
Passage Bio Inc (PASG) 순이익 2024
PASG은 2023-09-30 종료 분기에 대해 순이익(지난 12개월)이 -112.38M 달러로 보고했으며, 전년대비 +29.86% 증가했습니다.
Passage Bio Inc (PASG) 현금흐름 2024
2023-09-30 종료 분기에 PASG은 현금흐름(지난 12개월)으로 -83.38M 달러를 기록했으며, 전년 대비 +39.18% 증가했습니다.
Passage Bio Inc (PASG) 주당 순이익 2024
PASG이 보고한 2023-09-30 종료 분기의 주당 순이익(지난 12개월)은 -2.05달러이며, 전년 대비 +30.74% 성장했습니다.
Passage Bio Inc 주식 (PASG) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Borthwick Kathleen | SVP, INTERIM CFO |
Feb 13 '24 |
Sale |
0.97 |
1,470 |
1,426 |
28,466 |
Forman Mark S | Chief Medical Officer |
Jan 02 '24 |
Sale |
0.91 |
15,813 |
14,390 |
45,269 |
Cale Edgar B. | GC & Corporate Secretary |
Jan 02 '24 |
Sale |
0.91 |
15,813 |
14,390 |
45,995 |
King Simona | Chief Financial Officer |
Jul 28 '23 |
Option Exercise |
0.00 |
31,250 |
0 |
35,447 |
King Simona | Chief Financial Officer |
Jul 28 '23 |
Sale |
0.88 |
11,453 |
10,079 |
23,994 |
ORBIMED ADVISORS LLC | 10% Owner |
Jun 28 '23 |
Buy |
0.84 |
575,195 |
483,164 |
8,034,000 |
ORBIMED ADVISORS LLC | 10% Owner |
Jun 27 '23 |
Buy |
0.84 |
617,382 |
518,601 |
7,458,805 |
Fotopoulos Alexandros | Chief Technical Officer |
Jun 16 '23 |
Sale |
0.93 |
4,052 |
3,778 |
28,693 |
Fotopoulos Alexandros | Chief Technical Officer |
Jun 15 '23 |
Option Exercise |
0.00 |
12,500 |
0 |
32,745 |
자본화:
|
볼륨(24시간):